Andrew Hykes Inari Medical, Inc. (NARI) insider trading activity

Andrew Hykes is President and CEO of Inari Medical, Inc.. Currently has a direct ownership of 0 shares of NARI, which is worth approximately $0. The most recent transaction as insider was on Mar 12, 2023, when has been sold 430,517 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Andrew Hykes Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 12 2023	BUY Exercise of conversion of derivative security	-	430,517 Added 43.42%	561,112 Common Stock
Feb 21 2023	SELL Open market or private sale	$496,710 $55.19 p/Share	9,000 Reduced 6.45%	130,595 Common Stock
Feb 18 2023	BUY Grant, award, or other acquisition	-	46,549 Added 25.01%	139,595 Common Stock
Jan 20 2023	SELL Open market or private sale	$558,090 $62.01 p/Share	9,000 Reduced 8.82%	93,046 Common Stock
Jan 01 2023	SELL Payment of exercise price or tax liability	$72,776 $63.56 p/Share	1,145 Reduced 1.11%	101,853 Common Stock
Dec 20 2022	SELL Open market or private sale	$613,350 $68.15 p/Share	9,000 Reduced 8.04%	102,998 Common Stock
Nov 21 2022	SELL Open market or private sale	$699,120 $77.68 p/Share	9,000 Reduced 7.44%	111,998 Common Stock
Oct 20 2022	SELL Open market or private sale	$653,670 $72.63 p/Share	9,000 Reduced 6.92%	120,998 Common Stock
Oct 01 2022	SELL Payment of exercise price or tax liability	$72,132 $72.64 p/Share	993 Reduced 0.76%	129,998 Common Stock
Sep 06 2022	SELL Open market or private sale	$350,000 $70.0 p/Share	5,000 Reduced 3.68%	130,991 Common Stock
Aug 01 2022	SELL Open market or private sale	$392,350 $78.47 p/Share	5,000 Reduced 3.55%	135,991 Common Stock
Jul 05 2022	SELL Open market or private sale	$351,550 $70.31 p/Share	5,000 Reduced 3.42%	140,991 Common Stock
Jul 01 2022	SELL Payment of exercise price or tax liability	$68,179 $68.66 p/Share	993 Reduced 0.68%	145,991 Common Stock
Jun 07 2022	SELL Open market or private sale	$350,400 $70.08 p/Share	5,000 Reduced 3.29%	146,984 Common Stock
May 02 2022	SELL Open market or private sale	$398,250 $79.65 p/Share	5,000 Reduced 3.19%	151,984 Common Stock
Apr 01 2022	SELL Open market or private sale	$912,200 $91.22 p/Share	10,000 Reduced 5.99%	156,984 Common Stock
Apr 01 2022	SELL Payment of exercise price or tax liability	$90,284 $90.92 p/Share	993 Reduced 0.59%	166,984 Common Stock
Mar 16 2022	BUY Exercise of conversion of derivative security	$4,300 $0.43 p/Share	10,000 Added 5.62%	167,977 Common Stock
Mar 01 2022	SELL Open market or private sale	$1,242,775 $90.74 p/Share	13,696 Reduced 7.98%	157,977 Common Stock
Feb 28 2022	SELL Open market or private sale	$567,675 $90.05 p/Share	6,304 Reduced 3.54%	171,673 Common Stock
Feb 17 2022	BUY Grant, award, or other acquisition	-	29,879 Added 14.37%	177,977 Common Stock
Feb 01 2022	SELL Open market or private sale	$370,400 $74.08 p/Share	5,000 Reduced 3.27%	148,098 Common Stock
Jan 18 2022	SELL Open market or private sale	$384,550 $76.91 p/Share	5,000 Reduced 3.16%	152,979 Common Stock
Jan 01 2022	SELL Payment of exercise price or tax liability	$37,512 $91.27 p/Share	411 Reduced 0.3%	137,194 Common Stock
Dec 15 2021	SELL Open market or private sale	-	22,222 Reduced 13.9%	137,605 Common Stock

Andrew Hykes

President and CEO

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NARI shares.

Notify only if

Value

Insider Trading

Get notified when an Inari Medical, Inc. insider buys or sells NARI shares.

Notify only if

Operation

Value

Type

News

Receive news related to Inari Medical, Inc.

Track Activities on NARI

Account